JP2022527401A5 - - Google Patents

Info

Publication number
JP2022527401A5
JP2022527401A5 JP2021559994A JP2021559994A JP2022527401A5 JP 2022527401 A5 JP2022527401 A5 JP 2022527401A5 JP 2021559994 A JP2021559994 A JP 2021559994A JP 2021559994 A JP2021559994 A JP 2021559994A JP 2022527401 A5 JP2022527401 A5 JP 2022527401A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
compound
administered
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559994A
Other languages
English (en)
Japanese (ja)
Other versions
JP7596296B2 (ja
JP2022527401A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027981 external-priority patent/WO2020210823A1/en
Publication of JP2022527401A publication Critical patent/JP2022527401A/ja
Publication of JP2022527401A5 publication Critical patent/JP2022527401A5/ja
Application granted granted Critical
Publication of JP7596296B2 publication Critical patent/JP7596296B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559994A 2019-04-12 2020-04-13 炎症性障害を治療するための化合物および方法 Active JP7596296B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962833140P 2019-04-12 2019-04-12
US62/833,140 2019-04-12
PCT/US2020/027981 WO2020210823A1 (en) 2019-04-12 2020-04-13 Compounds and methods for treating inflammatory disorders

Publications (3)

Publication Number Publication Date
JP2022527401A JP2022527401A (ja) 2022-06-01
JP2022527401A5 true JP2022527401A5 (cg-RX-API-DMAC7.html) 2023-04-20
JP7596296B2 JP7596296B2 (ja) 2024-12-09

Family

ID=72751451

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021559994A Active JP7596296B2 (ja) 2019-04-12 2020-04-13 炎症性障害を治療するための化合物および方法

Country Status (9)

Country Link
US (2) US12398093B2 (cg-RX-API-DMAC7.html)
EP (2) EP4685135A3 (cg-RX-API-DMAC7.html)
JP (1) JP7596296B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220008264A (cg-RX-API-DMAC7.html)
CN (2) CN118384143A (cg-RX-API-DMAC7.html)
AU (1) AU2020271915B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020424A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136153A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020210823A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024528031A (ja) * 2021-07-26 2024-07-26 ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ 5-ht2応答性状態を治療するための化合物及び方法
SE2151519A1 (en) 2021-12-10 2023-06-11 Amidea Sweden Ab 2-(2,5-dimethoxyphenyl)ethanamine and uses thereof
WO2024010765A1 (en) * 2022-07-05 2024-01-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions for treating 5-ht2 conditions and methods of using the same
WO2024191924A2 (en) * 2023-03-10 2024-09-19 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods of use thereof
WO2025240982A1 (en) 2024-05-17 2025-11-20 2A Biosciences, Inc. 5-alkoxymethyl and 5-hydroxymethyl phenethylamines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877802B2 (en) * 2005-07-28 2014-11-04 Duke Univerity Antiparkinsonian action of phenylisopropylamines
US9642819B2 (en) * 2008-07-10 2017-05-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
EA035868B1 (ru) * 2012-08-17 2020-08-24 Смартек Интернэшнл Эл-Эл-Си Приготовление высушенных липосом для применения в системах выпуска в прессованном виде
US20200078335A1 (en) 2017-05-01 2020-03-12 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods to reduce pathogenesis
GB201715919D0 (en) 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Similar Documents

Publication Publication Date Title
JP2023504415A5 (cg-RX-API-DMAC7.html)
JP7498827B2 (ja) 線維症治療剤
JP2016500111A5 (cg-RX-API-DMAC7.html)
JP2023106403A5 (cg-RX-API-DMAC7.html)
JP2024516371A5 (cg-RX-API-DMAC7.html)
JP2017526716A5 (cg-RX-API-DMAC7.html)
JP6091593B2 (ja) 慢性閉塞性肺疾患の急性増悪の治療におけるピラゾール誘導体の使用
JP2024170583A5 (cg-RX-API-DMAC7.html)
JP2010515682A5 (cg-RX-API-DMAC7.html)
CN118742310B (zh) 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用
JP2019530674A5 (cg-RX-API-DMAC7.html)
JP2024544538A5 (cg-RX-API-DMAC7.html)
JP2006519824A5 (cg-RX-API-DMAC7.html)
JP2024531188A5 (cg-RX-API-DMAC7.html)
JP2022520990A (ja) 呼吸器疾患の治療の方法
JP2025118775A5 (cg-RX-API-DMAC7.html)
JP2016525573A5 (cg-RX-API-DMAC7.html)
US6455567B1 (en) Method of treatment
JP2023553253A5 (cg-RX-API-DMAC7.html)
JP2013518061A5 (cg-RX-API-DMAC7.html)
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
JP2023538419A5 (cg-RX-API-DMAC7.html)
JP2023538125A5 (cg-RX-API-DMAC7.html)
CN1127336C (zh) 肺性心病治疗剂
JP2024506291A5 (cg-RX-API-DMAC7.html)